Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$340K Sell
85,024
-375,487
-82% -$1.43M ﹤0.01% 3770
2026
Q1
$1.84M Sell
460,511
-11,981
-3% -$41.8K ﹤0.01% 3021
2025
Q4
$1.78M Sell
472,492
-40,507
-8% -$166K ﹤0.01% 3066
2025
Q3
$2.25M Sell
512,999
-20,868
-4% -$106K ﹤0.01% 2970
2025
Q2
$3.52M Buy
533,867
+400,440
+300% +$2.35M ﹤0.01% 2672
2025
Q1
$676K Sell
133,427
-3,471
-3% -$19.7K ﹤0.01% 3447
2024
Q4
$806K Buy
136,898
+97,239
+245% +$637K ﹤0.01% 3478
2024
Q3
$295K Buy
+39,659
New +$276K ﹤0.01% 3748

Other funds holding VTEX

Northern Trust's VTEX Position: Q2 2026 in Review

Northern Trust reduced its VTEX (VTEX) stake by 82% in Q2 2026, selling an estimated $1.43M and leaving 85,024 shares worth $340K. The position accounts for ﹤0.01% of the portfolio, ranked #3770.

Northern Trust first reported a position in VTEX in Q3 2024 and has held it in 8 quarters since. The position peaked at $3.52M in Q2 2025. 109 funds tracked by Wall St. Rank hold VTEX as of Q2 2026.

  • Northern Trust held 85,024 shares of VTEX worth $340K as of Q2 2026.
  • Northern Trust sold 375,487 VTEX shares in Q2 2026, an estimated $1.43M.
  • VTEX made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #3770 holding.
  • Northern Trust first reported a position in VTEX in Q3 2024 and has held it in 8 quarters since.
  • Northern Trust's VTEX position peaked at $3.52M in Q2 2025.
  • 109 funds tracked by Wall St. Rank held VTEX as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.